Loading clinical trials...
Loading clinical trials...
The aim of this study is to examine if high-volume plasma exchange has a positive effect on mortality in patients with acute liver failure.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Rigshospitalet, Denmark
NCT07329036 · Acute Liver Failure
NCT06831643 · Acute Liver Failure
NCT06872372 · Acute Liver Failure, Drug-Induced Liver Injury
NCT06285253 · Acute Liver Failure, Acute Liver Injury, Drug Induced, and more
NCT07276568 · Acute Liver Failure, Acute on Chronic Liver Failure (ACLF), and more
Department of Hepatology, Rigshospitalet
Copenhagen, DK
Department of Transplantation and Liver Surgery, Helsinki University Hospital
Helsinki
Institute of Liver Studies, King's College Hospital
London
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions